#USA #New York #Securities Fraud #Rosen Law Firm #Dentsply Sirona

Investors Alert: Potential Class Action Against Dentsply Sirona Inc.

In a significant legal development, the Rosen Law Firm, a prominent global investor rights firm, has made an important announcement for those who purchased common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) during the specified class period from December 1, 2022, to November 6, 2024. This disclosure comes with an invitation for affected investors to consider joining a class action lawsuit due to alleged securities fraud.

What's Happening?

The class action claims that Dentsply Sirona made multiple misleading statements and failed to disclose critical information that could have significantly affected stockholder decisions. Investors who bought shares during this time frame might now have grounds to seek compensation. The lead plaintiff deadline is set for January 27, 2025, with interested parties urged to take prompt action.

Crucial Steps to Take

If you believe you qualify to be part of this class action, you can submit your information through the Rosen Law Firm's designated form at rosenlegal.com or contact Phillip Kim, Esq. at 866-767-3653. It’s vital to act quickly as the court may require certain filings by January 13, 2025, for anyone interested in being a lead plaintiff. The role of a lead plaintiff involves representing other class members in the proceedings.

Why Choose Rosen Law Firm?

Investors are advised to carefully select their legal representation, a choice the Rosen Law Firm urges given its extensive experience and successful track record in securities class actions. This firm has previously achieved notable settlements, including one of the largest against a Chinese company, and has repeatedly ranked among the leaders in the field. Investors can take solace in the firm's specialization in these cases, as opposed to others which may simply refer clients elsewhere.

Allegations Overview

Details surrounding the lawsuit have painted a troubling picture of Dentsply Sirona's practices. Key allegations suggest:
1. Targeting Vulnerable Patients: Dentsply is accused of marketing its direct-to-consumer aligner service, Byte, to individuals lacking proper dental care access, leading to treatments for those unsuitable for such services.
2. Sales Pressure: There is a claim that internal sales pressures led employees to sell to patients who were contraindicated, compromising patient care and safety.
3. Injury Reports Ignored: Reports indicate that Dentsply knew of numerous cases where patients suffered injuries as a result of Byte's aligners but failed to adequately investigate or notify regulatory bodies.
4. Overstated Business Health: Allegedly, Dentsply misrepresented the value of its Byte segment, resulting in a substantial overestimation of goodwill.

As the true information about these practices surfaced, associated losses for investors became apparent, raising serious concerns over the company's operations and the integrity of its public statements.

Next Steps

If you wish to pursue your rights as part of the class action lawsuit, please visit the class action submission page or reach out to Rosen Law Firm for assistance. As no class has been certified yet, investors must act sooner rather than later to ensure they get the representation they need.

In the world of investments and stocks, staying informed is key. Follow the developments closely and consider the implications of the ongoing issues surrounding Dentsply Sirona. Investors should engage with qualified legal counsel to evaluate their positions and options moving forward.

For updates, investors can connect with the firm on social media platforms like LinkedIn, Twitter, and Facebook.

Conclusion

As the Dentsply Sirona class action unfolds, it promises to be a pivotal moment for investors impacted by the alleged deceptive practices of the company. The Rosen Law Firm stands ready to assist those looking to protect their rights and potentially recover their losses.

Invest wisely and stay vigilant.